Loading…

Watchlist

Sign Up / LoginLogin

Overview Financials Estimates Ownership Dividends Filings Ratios Segments & KPIs Peers

Apimeds Pharmaceuticals US, Inc (APUS) — SEC filings

Recent SEC filings for Apimeds Pharmaceuticals US, Inc — 10-K, 10-Q, 8-K, proxy statements, and insider transactions.

Loading…

Quant Auras

Institutional-grade financial analytics for modern investors.

Platform

Screener Heatmap Watchlist

Resources

Legal

Privacy Policy Terms of Service

Important. Quant Auras is not a registered broker-dealer or investment advisor. Information on this site is for educational purposes only and does not constitute financial advice or a solicitation to buy or sell securities.

Market data provided by Financial Modeling Prep.

© 2026 Quant Auras.

STATUS: OPERATIONAL